Email this article How to manage patients with atrial fibrillation in a general hospital
- Authors: Nazarenko GI1, Lazebnik LВ1, Zamiro TN1, Kashevskaya OP1
-
Affiliations:
- Медицинский центр Банка России
- Issue: Vol 79, No 8 (2004)
- Pages: 47-47
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/29892
- ID: 29892
Cite item
Full Text
Abstract
Aim. To evaluate efficacy of use of technological charts (TC) in upgrading management and treatment
safety in patients with atrial fibrillation (AF).
Material and methods. Two groups of AF patients were compared: 196 patients treated before introduction of TC (group 1) and 431 patients managed according to TC technology (group 2).
Results. In group 2 treatment duration reduced from 26.1 to 18.5 days, ^hospitalizations occurred by
6% less frequently, number of unexpected side effects fell 2.5-fold, the rate ofvarfarin prescription for
prevention of thromboembolic complications rose from 18 to 64%, the patients were satisfied with the
treatment in 97% vs past 79%.
Conclusion. TC was a tool of treatment improvement and introduction of the latest clinical recommendations into clinical practice with reference to facilities and staff qualification of an individual hospital
without additional financial input.
safety in patients with atrial fibrillation (AF).
Material and methods. Two groups of AF patients were compared: 196 patients treated before introduction of TC (group 1) and 431 patients managed according to TC technology (group 2).
Results. In group 2 treatment duration reduced from 26.1 to 18.5 days, ^hospitalizations occurred by
6% less frequently, number of unexpected side effects fell 2.5-fold, the rate ofvarfarin prescription for
prevention of thromboembolic complications rose from 18 to 64%, the patients were satisfied with the
treatment in 97% vs past 79%.
Conclusion. TC was a tool of treatment improvement and introduction of the latest clinical recommendations into clinical practice with reference to facilities and staff qualification of an individual hospital
without additional financial input.
About the authors
G I Nazarenko
Медицинский центр Банка РоссииМедицинский центр Банка России
L В Lazebnik
Медицинский центр Банка РоссииМедицинский центр Банка России
T N Zamiro
Медицинский центр Банка РоссииМедицинский центр Банка России
O P Kashevskaya
Медицинский центр Банка РоссииМедицинский центр Банка России
References
- Godtfredsen J. Epidemiology and costs of cardiac arrhythmias.In: Godtfredsen J., Falk R. (eds) Cardiac arrhythmias. A clinical approach. St. Louis: Mosby; 2003. 3-26.
- Khairy P., Nattel S. New insights into the mechanisms and management of atrial fibrillation. Can. Med. Assoc. J. 2002; 167 (9): 1012-1020.
- Go A. S., Hylek E. M., Kathleen A. P. et al. Prevalence of diagnosed atrial fibrillation in adults. National implication for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. J. A. M. A. 2001; 285 (18): 2370-2375.
- Wolf P. A., Abbott R. D., Kannel W. B. Atrial fibrillation as an independent risk factor for stroke: The Framingham study. Stroke 1991; 22: 983-988.
- Godtfredsen J. Management of acute atrial fibrillation and other supraventricular arrhythmias. In: Godtfredsen J., Falk R. (eds.) Cardiac arrhythmias. A clinical approach. St. Louis: Mosby; 2003. 263-295.
- Levy S., Maarek M., Coumel P. et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. Circulation 1999; 99 (23): 3028-3035.
- Camm A. J. Safety of antiarrhythmic agents: The final frontier in treating atrial fibrillation? www.medscape.com/Medscape/ <http://www.medscape.com/Medscape/>cardiology/Treatment Update/2000/tu03.
- Benavente O., Hart R., Koudstaal P. et al. Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks (Cochrane Review). Cochrane Library 2000; Iss. 3.
- Gage B. F., Boechler M., Doggette M. A. et al. Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation. Stroke 2000; 31: 822-827.
- Segal J. В., McNamara R. L., Miller M. R. et al. Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter. Cochrane Library 2001; Iss. 1.
- Hart R. G., Halperin J. L., Pearce L. A. et al. Lessons from the stroke prevention in atrial fibrillation trial. Ann. Intern. Med. 2003; 138: 831-838.
- Duff L. A., Kitson A. L., Seers K, Humphris D. Clinical guidelines: an introduction to their development and implementation. J. Adv. Nurs. 1996; 23 (5): 887-895.
- Field M. J., Lohr K. N. (eds) Institute of medicine. Guidelines for clinical practice: from development to use. Washington: National Academy Press: 1992. 165.
- Johnson S. (ed.) Pathways of care. Oxford: Blackwall Sci.; 1997.
- Назаренко Г. И., Полубенцева Е. И. Управление качеством медицинской помощи. М.: Медицина; 2000.
- Назаренко Г. И., Полубенцева Е. И. (ред.) Проектирование медицинских технологических процессов (подготовка технологической карты ведения больного): Учеб.-метод, пособие. М.: Медицинский центр Банка России; 2001.
- Weingarten S. Practice guidelines and clinical pathways. In:Wachter R. et al. (eds.) Hospital medicine. Philadelphia: Lippincott Williams & Wilkins; 2000.
- Назаренко Г. И., Полубенцева Е. И. Смена парадигмы управления больницей как альтернатива "двойным" стандартам медицинской помощи. Пробл. управл. здравоохр. 2003; 2 (9): 25-36.
- Fuster V., Ryden L. E., Asinger R. W. et al. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation. A report of the ACC/AHA Task Force on Practice Guidelines, and the ESC Committee for Practice Guidelines and Policy Conference (Committeed to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur. Heart J. 2001; 22: 1852-1923.
- Kerr E., Asch S., Hamilton E., McGlynn E. Quality of care for general medical conditions: A review of the literature and quality indicators. www.rand.org/publications/MR/MR1280 <http://www.rand.org/publications/MR/MR1280>. - P. 49-67.
- Eisenberg J., Forlini J., Jollis J. et al. AHA/АСА 2nd Scientific Forum on quality of care and outcomes research in cardiovascular disease and stroke. www.medscape.com/Medscape/cardi- <http://www.medscape.com/Medscape/cardi->ology/CNO/2000.
- Sutton P. R., Yeh J. Y. Management of atrial fibrillation. Casestudy and commentary. J. Clin. Outcom. Manage 2002; 9 (11): 631-647.
Supplementary files
